TR201716155A1 - Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. - Google Patents

Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. Download PDF

Info

Publication number
TR201716155A1
TR201716155A1 TR2017/16155A TR201716155A TR201716155A1 TR 201716155 A1 TR201716155 A1 TR 201716155A1 TR 2017/16155 A TR2017/16155 A TR 2017/16155A TR 201716155 A TR201716155 A TR 201716155A TR 201716155 A1 TR201716155 A1 TR 201716155A1
Authority
TR
Turkey
Prior art keywords
corticosteroid
agonist
beta
combination
pharmaceutical formulation
Prior art date
Application number
TR2017/16155A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/16155A priority Critical patent/TR201716155A1/en
Publication of TR201716155A1 publication Critical patent/TR201716155A1/en

Links

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, vilanterol ve flutikazondan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.The present invention relates to pharmaceutical formulations in dry powder form comprising vilanterol and fluticasone for use in respiratory ailments.

TR2017/16155A 2017-10-19 2017-10-19 Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist. TR201716155A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/16155A TR201716155A1 (en) 2017-10-19 2017-10-19 Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/16155A TR201716155A1 (en) 2017-10-19 2017-10-19 Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist.

Publications (1)

Publication Number Publication Date
TR201716155A1 true TR201716155A1 (en) 2019-05-21

Family

ID=67954790

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/16155A TR201716155A1 (en) 2017-10-19 2017-10-19 Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist.

Country Status (1)

Country Link
TR (1) TR201716155A1 (en)

Similar Documents

Publication Publication Date Title
CY1120684T1 (en) DRY DUST PREPARATION THAT CONTAINS A CORTICOSTEROIDS AND A BETA-ADRENERGIC FOR INHALATION
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
MA41496A (en) PHARMACEUTICAL COMPOSITIONS COMPRISING N- (3,5-DIMETHOXYPHENYL) -N '- (1-METHYLETHYL) -N- [3- (1-METHYL-1H-PYRAZOL-4-YL) QUINOXALIN-6-YL] ETHANE-1 , 2-DIAMINE
CL2015001984A1 (en) (divisional sol. 1567-2013) combinations of active ingredients comprising pyridylethylbenzamides and other active ingredients.
CY1124490T1 (en) A PROCESS FOR THE PREPARATION OF A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC
BR112015018087A8 (en) compound, pharmaceutical composition and use
CO2019008103A2 (en) Pharmaceutical compositions for combination therapy
BR112019007459A2 (en) antifungal dry powders
GT201400182A (en) NEW PHARMACEUTICAL FORMULATIONS
BR112019001233A2 (en) pharmaceutical formulation and use thereof
MX2015015132A (en) Inhalable pharmaceutical compositions and the inhaler devices containing them.
CL2017002214A1 (en) Combination formulation of tesofensin and beta blocker
CO2017001601A2 (en) 1-Acetyl-4 - ((pyrazin-2-yl) amino) -1,2,3,4-tetrahydroquinoline-6 carboxamide derivatives as bromodomain inhibitors
UY34931A (en) ? COMPOSITE FORMULATION FOR ORAL ADMINISTRATION THAT INCLUDES METFORMIN AND ROSUVASTATIN ?.
CO2018014217A2 (en) Pharmaceutical compositions comprising safinamide
UY37261A (en) COMBINED FORMULATION OF THREE ANTIVIRAL COMPOUNDS
TR201902687T4 (en) Methods and systems for conditioning coarse crystalline materials.
TR201716155A1 (en) Pharmaceutical formulation containing a corticosteroid in combination with a beta-2 agonist.
CL2018003338A1 (en) Physiologically balanced injectable formulations of fosnetupitant.
PH12018502139A1 (en) Phosphaplatin liquid formulations
CL2018002542A1 (en) Na2-imp dehydrated as anti-caking agent
CO2017003989A2 (en) Herbicidal composition and process to prepare it
TR201714728A1 (en) Dry powder formulation containing Beta-2 Agonist and Corticosteroid.
IT201700025738A1 (en) Pharmaceutical composition comprising resveratrol and polymyxins for use as an antibacterial agent
TR201714893A1 (en) Dry powder composition containing Beta-2 Agonist and Corticosteroid.